Education
About Us
Working with TipRanks
Follow Us
Nuo Therapeutics (AURX)
OTHER OTC:AURX
AURX Stock Chart & Stats
Day’s Range― - ―
52-Week Range$0.25 - $1.76
Previous CloseN/A
Volume8.36K
Average Volume (3M)1.68K
Market Cap
$62.91M
Enterprise ValueN/A
Total Cash (Recent Filing)$636.93K
Total Debt (Recent Filing)$309.01K
Price to Earnings (P/E)―
Beta-0.32
Next EarningsN/A
EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)-0.06
Shares Outstanding46,598,404
10 Day Avg. Volume2,878
30 Day Avg. Volume1,682
Financial Highlights & Ratios
PEG RatioN/A
Price to Book (P/B)N/A
Price to Sales (P/S)47.40
Price to Cash Flow (P/CF)-28.40
P/FCF Ratio0.00
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
---
Nuo Therapeutics News
---
Ownership Overview
43.40% Insiders
―
Mutual Funds
― Other Institutional Investors
56.60% Public Companies and
Individual Investors
Risk Analysis
Main Risk Category
Finance & CorporateFinancial and accounting risks. Risks related to the execution of corporate activity and strategy
AURX FAQ
What was Nuo Therapeutics’s price range in the past 12 months?
Nuo Therapeutics lowest stock price was $0.25 and its highest was $1.76 in the past 12 months.
What is Nuo Therapeutics’s market cap?
Nuo Therapeutics’s market cap is $62.91M.
When is Nuo Therapeutics’s upcoming earnings report date?
The company’s upcoming earnings report date is not yet available.
How were Nuo Therapeutics’s earnings last quarter?
Currently, no data Available
Is Nuo Therapeutics overvalued?
According to Wall Street analysts Nuo Therapeutics’s price is currently Overvalued.
Does Nuo Therapeutics pay dividends?
Nuo Therapeutics does not currently pay dividends.
What is Nuo Therapeutics’s EPS estimate?
Nuo Therapeutics’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does Nuo Therapeutics have?
Nuo Therapeutics has 46,598,404 shares outstanding.
What happened to Nuo Therapeutics’s price movement after its last earnings report?
Currently, no data Available
Which hedge fund is a major shareholder of Nuo Therapeutics?
Currently, no hedge funds are holding shares in AURX
---
Company Description
Nuo Therapeutics
Nuo Therapeutics, Inc., a regenerative therapies company, develops, commercializes, and markets cell-based technologies that harness the regenerative capacity of the human body to trigger natural healing primarily in the United States. Its technology separates autologous blood to produce a platelet based therapy for the chronic wound care market. The company was formerly known as Cytomedix, Inc. and changed its name to Nuo Therapeutics, Inc. in November 2014. Nuo Therapeutics, Inc. was founded in 1998 and is based in Houston, Texas.
---
Technical Analysis
---